Skip to main content

Animations

Foundation Updates

Read expert commentary, insights and general announcements on how the Foundation is paving the way for Parkinson's research.



  • Woman wearing gloves and a white coat holding a long pipette with a man in a lab coat watching in the background.

    How Strategic De-Risking is Fueling Parkinson’s Treatment Development

    MJFF highlights how strategic de-risking and targeted investments accelerate Parkinson’s therapies, from genetic treatments to adaptive deep brain stimulation.
    Learn more Save for later

  • Doctor and two people in clinic room

    Research Roundup: Join Clinical Trials that Address Parkinson’s Progression and Symptoms

    Learn about clinical studies that are open for enrollment and aim to treat Parkinson’s symptoms and slow disease progression.
    Learn more Save for later

  • Targets to Therapies Image

    Targets to Therapies Annual Meeting Launches Next Wave of Parkinson’s Drug Targets

    MJFF’s first Targets to Therapies Annual Meeting launched the next wave of Parkinson’s drug targets, advancing validation, tools and collaboration across the field.
    Learn more Save for later

  • Two purple-gloved hands holding a test tube containing a pink liquid in a laboratory setting.

    Stem Cell Therapy for Parkinson’s Given Limited Approval in Japan

    Japan has conditionally approved the first stem cell-based therapy for Parkinson’s disease.
    Learn more Save for later

  • Two people smiling looking at laptop

    Speed Studies that Need You: Using “Fox Trial Finder”

    Fox Trial Finder has new updates, including better search and filtering options to browse Parkinson’s studies, even virtual ones you can join from the comfort of your own home.
    Learn more Save for later

Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.